Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank W G Leebeek

Showing results (1-10 of 287) with videos related to

Pageof 29
Sort By:
Blood|December 29, 2022
A novel VWF-associated thrombolytic agentFrank W G Leebeek
The Lancet. Haematology|June 29, 2023
Heavy menstrual blood loss in patients with von Willebrand disease: an unsolved problemFrank W G Leebeek
Hemasphere|June 7, 2021
New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand SyndromeFrank W G Leebeek
Blood|January 26, 2019
A prothrombotic von Willebrand factor variantFrank W G Leebeek
Thrombosis Research|April 13, 2016
Update of thrombosis in multiple myelomaFrank W G Leebeek
Blood|November 25, 2017
Low VWF: an established mild bleeding disorder?Frank W G Leebeek, Johan Boender
Digestive Surgery|July 28, 2007
Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatmentTon Lisman, Frank W G Leebeek
British Journal of Haematology|September 10, 2019
How I manage severe von Willebrand diseaseFrank W G Leebeek, Ferdows Atiq
Blood|July 7, 2021
Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issuesFrank W G Leebeek, Wolfgang Miesbach
Blood Transfusion = Trasfusione Del Sangue|June 13, 2014
Quality of haemophilia care in The Netherlands: new standards for optimal careFrank W G Leebeek, Kathelijn Fischer
Pageof 29

Showing results (1-10 of 287) with videos related to

Sort By:
Pageof 29
Blood|December 29, 2022
A novel VWF-associated thrombolytic agentFrank W G Leebeek
The Lancet. Haematology|June 29, 2023
Heavy menstrual blood loss in patients with von Willebrand disease: an unsolved problemFrank W G Leebeek
Hemasphere|June 7, 2021
New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand SyndromeFrank W G Leebeek
Blood|January 26, 2019
A prothrombotic von Willebrand factor variantFrank W G Leebeek
Thrombosis Research|April 13, 2016
Update of thrombosis in multiple myelomaFrank W G Leebeek
Blood|November 25, 2017
Low VWF: an established mild bleeding disorder?Frank W G Leebeek, Johan Boender
Digestive Surgery|July 28, 2007
Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatmentTon Lisman, Frank W G Leebeek
British Journal of Haematology|September 10, 2019
How I manage severe von Willebrand diseaseFrank W G Leebeek, Ferdows Atiq
Blood|July 7, 2021
Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issuesFrank W G Leebeek, Wolfgang Miesbach
Blood Transfusion = Trasfusione Del Sangue|June 13, 2014
Quality of haemophilia care in The Netherlands: new standards for optimal careFrank W G Leebeek, Kathelijn Fischer
Pageof 29